Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies
Steven P. Treon(Dana-Farber Cancer Institute), Jorge J. Castillo(Dana-Farber Cancer Institute), Irene M. Ghobrial(Dana-Farber Cancer Institute), Zachary R. Hunter(Harvard University), Christopher J. Patterson(Dana-Farber Cancer Institute), Cristina Jiménez(Central European Institute of Technology), Andrew R. Branagan(Massachusetts General Hospital), Amanda Kofides(Shaanxi Research Association for Women and Family), Gloria Chan(Shaanxi Research Association for Women and Family), Maria Demos(Shaanxi Research Association for Women and Family), Xia Liu(Harvard University), Nicholas Tsakmaklis(Shaanxi Research Association for Women and Family), Maria Luisa Guerrera(Harvard University), Andrew Keezer(Dana-Farber Cancer Institute), Manit Munshi(Dana-Farber Cancer Institute), Romanos Sklavenitis‐Pistofidis(Broad Institute), Joshua Gustine(Boston University), Kirsten Meid(Shaanxi Research Association for Women and Family), Aldo M. Roccaro(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Jiaji G. Chen(Shaanxi Research Association for Women and Family), Guang Yang(Blueprint Medicines (United States)), Mark Bustoros(Harvard University), Lian Xu(Huazhong Agricultural University), Antonio Sacco(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)
Cited by 165
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
|Blood|2001|905
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
|Journal of Clinical Investigation|2013|782
Immunopathology of Hyperinflammation in COVID-19
|American Journal Of Pathology|2020|526
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
|New England Journal of Medicine|2022|457